dc.creatorPaiva-Fonseca, F
dc.creatorSantos-Silva, A-R
dc.creatorDella-Coletta, R
dc.creatorVargas, P-A
dc.creatorLopes, M-A
dc.date2014-Mar
dc.date2015-11-27T13:42:02Z
dc.date2015-11-27T13:42:02Z
dc.date.accessioned2018-03-29T01:19:56Z
dc.date.available2018-03-29T01:19:56Z
dc.identifierMedicina Oral, Patología Oral Y Cirugía Bucal. v. 19, n. 2, p. e106-11, 2014-Mar.
dc.identifier1698-6946
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/23986020
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/201188
dc.identifier23986020
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1301421
dc.descriptionBisphosphonates is a group of inorganic pyrophosphates analogues that suppress bone resorption by inducing osteoclast inactivation, being frequently used for management of diseases affecting bone metabolism, bone metastases and bone tumors. However, since 2003 many cases describing the presence of necrotic bone exposures in the jaws have been described in patients receiving these drugs, what represent a significant complication of bisphosphonates treatment. The overall incidence of bisphosphonate-related osteonecrosis of the jaws is low, ranging from 0.7% to 12%, mainly observed in those patients receiving intravenously treatment. Osteonecrosis of the jaws associated to oral bisphosphonate, particularly alendronate, has also been reported by a number of authors. Considering that alendronate is one of the most used drug worldwide, specially for treatment of osteoporosis, a better understanding of osteonecrosis of the jaws related to its use and how to manage these patients is extremely important. Therefore, in the current manuscript the authors aim to review the most important topics related to this pathological presentation.
dc.description19
dc.descriptione106-11
dc.languageeng
dc.relationMedicina Oral, Patología Oral Y Cirugía Bucal
dc.relationMed Oral Patol Oral Cir Bucal
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAlendronate
dc.subjectBisphosphonate-associated Osteonecrosis Of The Jaw
dc.subjectBone Density Conservation Agents
dc.subjectHumans
dc.titleAlendronate-associated Osteonecrosis Of The Jaws: A Review Of The Main Topics.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución